CK2-dependent SK channel dysfunction as contributor to neuronal hyperexcitability in Alzheimer's disease
- PMID: 39757072
- DOI: 10.1016/j.tins.2024.12.006
CK2-dependent SK channel dysfunction as contributor to neuronal hyperexcitability in Alzheimer's disease
Abstract
Neuronal hyperexcitability in the cortex and hippocampus represents an early event in Alzheimer's disease (AD). In a recent study, Blankenship and colleagues reported that in a mouse of AD, ventral tegmental area (VTA) dopamine neurons are also hyperexcitable, and this hyperexcitability is due to casein kinase 2 (CK2)-dependent SK channel dysfunction, adding new insights into the underlying mechanisms of aberrant neuronal properties in AD.
Keywords: circuit pathology; dopamine neuron; ion channel; memory; neurodegeneration; ventral tegmental area.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
VTA dopamine neurons are hyperexcitable in 3xTg-AD mice due to casein kinase 2-dependent SK channel dysfunction.Nat Commun. 2024 Nov 8;15(1):9673. doi: 10.1038/s41467-024-53891-1. Nat Commun. 2024. PMID: 39516200 Free PMC article.
-
Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's disease.J Alzheimers Dis. 2025 Feb;103(4):1112-1125. doi: 10.1177/13872877241309120. Epub 2025 Jan 10. J Alzheimers Dis. 2025. PMID: 39791382 Free PMC article.
-
Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.Elife. 2024 Jan 29;12:RP89453. doi: 10.7554/eLife.89453. Elife. 2024. PMID: 38285009 Free PMC article.
-
Nimodipine for primary degenerative, mixed and vascular dementia.Cochrane Database Syst Rev. 2001;(1):CD000147. doi: 10.1002/14651858.CD000147. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2002;(3):CD000147. doi: 10.1002/14651858.CD000147. PMID: 11279679 Updated.
-
CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.Int J Mol Sci. 2023 May 4;24(9):8230. doi: 10.3390/ijms24098230. Int J Mol Sci. 2023. PMID: 37175935 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical